vs
芝商所（CME）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
芝商所的季度营收约是瑞思迈的1.3倍（$1.9B vs $1.4B），瑞思迈净利率更高（27.6% vs 0.1%，领先27.5%），芝商所同比增速更快（14.5% vs 11.0%），过去两年芝商所的营收复合增速更高（10.8% vs 7.9%）
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业，为全球规模最大的金融衍生品交易所运营商，旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台，覆盖农产品、货币、能源等品类交易，同时持有标普道琼斯指数27%的股权。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CME vs RMD — 直观对比
营收规模更大
CME
是对方的1.3倍
$1.4B
营收增速更快
CME
高出3.5%
11.0%
净利率更高
RMD
高出27.5%
0.1%
两年增速更快
CME
近两年复合增速
7.9%
损益表 — Q1 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.9B | $1.4B |
| 净利润 | $1.2M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 0.1% | 34.6% |
| 净利率 | 0.1% | 27.6% |
| 营收同比 | 14.5% | 11.0% |
| 净利润同比 | 20.7% | 13.9% |
| 每股收益（稀释后） | — | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMERMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.5B | $1.3B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.6B | $1.2B |
净利润CMERMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | $1.2M | — | ||
| Q4 25 | $1.2B | $392.6M | ||
| Q3 25 | $908.0M | $348.5M | ||
| Q2 25 | $1.0B | $379.7M | ||
| Q1 25 | $956.2M | $365.0M | ||
| Q4 24 | $874.6M | $344.6M | ||
| Q3 24 | $912.8M | $311.4M |
毛利率CMERMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% |
营业利润率CMERMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | 0.1% | — | ||
| Q4 25 | 61.8% | 34.6% | ||
| Q3 25 | 63.3% | 33.4% | ||
| Q2 25 | 66.7% | 33.7% | ||
| Q1 25 | 67.5% | 33.0% | ||
| Q4 24 | 62.1% | 32.5% | ||
| Q3 24 | 64.6% | 31.6% |
净利率CMERMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | 0.1% | — | ||
| Q4 25 | 71.7% | 27.6% | ||
| Q3 25 | 59.1% | 26.1% | ||
| Q2 25 | 60.6% | 28.2% | ||
| Q1 25 | 58.2% | 28.3% | ||
| Q4 24 | 57.3% | 26.9% | ||
| Q3 24 | 57.6% | 25.4% |
每股收益（稀释后）CMERMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | — | ||
| Q4 25 | $3.24 | $2.68 | ||
| Q3 25 | $2.49 | $2.37 | ||
| Q2 25 | $2.81 | $2.58 | ||
| Q1 25 | $2.62 | $2.48 | ||
| Q4 24 | $2.40 | $2.34 | ||
| Q3 24 | $2.50 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $1.4B |
| 总债务越低越好 | $3.4B | $663.8M |
| 股东权益账面价值 | — | $6.3B |
| 总资产 | $202.0B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资CMERMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $2.4B | — | ||
| Q4 25 | $4.5B | $1.4B | ||
| Q3 25 | $2.6B | $1.4B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $1.5B | $932.7M | ||
| Q4 24 | $3.0B | $521.9M | ||
| Q3 24 | $2.4B | $426.4M |
总债务CMERMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | $3.4B | — | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益CMERMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | — | ||
| Q4 25 | $28.7B | $6.3B | ||
| Q3 25 | $28.2B | $6.1B | ||
| Q2 25 | $27.7B | $6.0B | ||
| Q1 25 | $27.0B | $5.5B | ||
| Q4 24 | $26.5B | $5.3B | ||
| Q3 24 | $28.2B | $5.2B |
总资产CMERMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | $202.0B | — | ||
| Q4 25 | $198.4B | $8.5B | ||
| Q3 25 | $187.1B | $8.3B | ||
| Q2 25 | $179.9B | $8.2B | ||
| Q1 25 | $157.8B | $7.6B | ||
| Q4 24 | $137.4B | $7.1B | ||
| Q3 24 | $137.8B | $7.2B |
负债/权益比CMERMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
